Dongfeng Wu

571 total citations
44 papers, 378 citations indexed

About

Dongfeng Wu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Dongfeng Wu has authored 44 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Dongfeng Wu's work include Colorectal Cancer Screening and Detection (13 papers), Global Cancer Incidence and Screening (11 papers) and Genetic factors in colorectal cancer (6 papers). Dongfeng Wu is often cited by papers focused on Colorectal Cancer Screening and Detection (13 papers), Global Cancer Incidence and Screening (11 papers) and Genetic factors in colorectal cancer (6 papers). Dongfeng Wu collaborates with scholars based in United States and China. Dongfeng Wu's co-authors include Gary L. Rosner, Lyle D. Broemeling, Seongho Kim, Guy Brock, N. Shesh, Jack C. McCarty, Johnie N. Jenkins, Jixiang Wu, Xiaohong Li and Adriana Pérez and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Biometrics.

In The Last Decade

Dongfeng Wu

40 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dongfeng Wu United States 11 136 85 70 59 42 44 378
James Lindsay United States 10 143 1.1× 77 0.9× 184 2.6× 11 0.2× 6 0.1× 29 428
Junheng Gao United States 13 193 1.4× 210 2.5× 63 0.9× 43 0.7× 8 0.2× 25 412
Yushu Shi United States 10 102 0.8× 38 0.4× 209 3.0× 32 0.5× 12 0.3× 22 409
Hong Jae Jo South Korea 11 91 0.7× 94 1.1× 44 0.6× 122 2.1× 24 320
William B. Hamlin United States 8 72 0.5× 50 0.6× 19 0.3× 56 0.9× 6 0.1× 14 386
Xanthippi Tseretopoulou United Kingdom 7 46 0.3× 50 0.6× 39 0.6× 42 0.7× 2 0.0× 14 389
Qiufei Ma United States 10 173 1.3× 16 0.2× 49 0.7× 7 0.1× 7 0.2× 51 301
Nobuhiro Saruki Japan 9 71 0.5× 54 0.6× 114 1.6× 46 0.8× 30 354
Nelson D. Holmquist United States 9 33 0.2× 50 0.6× 35 0.5× 96 1.6× 48 1.1× 19 316

Countries citing papers authored by Dongfeng Wu

Since Specialization
Citations

This map shows the geographic impact of Dongfeng Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dongfeng Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dongfeng Wu more than expected).

Fields of papers citing papers by Dongfeng Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dongfeng Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dongfeng Wu. The network helps show where Dongfeng Wu may publish in the future.

Co-authorship network of co-authors of Dongfeng Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Dongfeng Wu. A scholar is included among the top collaborators of Dongfeng Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dongfeng Wu. Dongfeng Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qinglian, Jiangong Lin, Hui Han, et al.. (2022). Preoperative Cardiac Index as a Predictor of Maturation and Primary Patency of Radiocephalic Arteriovenous Fistula in Hemodialysis. Blood Purification. 51(11). 932–942. 2 indexed citations
2.
He, Jiajia, Lei Shang, Ning Jiao, et al.. (2021). High expression of protein phosphatase 2 regulatory subunit B'' alpha predicts poor outcome in hepatocellular carcinoma patients after liver transplantation. World Journal of Gastrointestinal Oncology. 13(7). 716–731. 5 indexed citations
3.
Liu, Ruiqi, Adriana Pérez, & Dongfeng Wu. (2018). Estimation of Lead Time via Low-Dose CT in the National Lung Screening Trial. PubMed. 2(4). 353–366. 3 indexed citations
4.
Li, Xiaohong, Guy Brock, Eric C. Rouchka, et al.. (2017). A comparison of per sample global scaling and per gene normalization methods for differential expression analysis of RNA-seq data. PLoS ONE. 12(5). e0176185–e0176185. 51 indexed citations
5.
Liu, Ruiqi, Dongfeng Wu, Xiang Zhang, & Seongho Kim. (2016). Compound Identification Using Penalized Linear Regression on Metabolomics. Journal of Modern Applied Statistical Methods. 15(1). 373–388. 2 indexed citations
6.
Duan, Xinyuan, et al.. (2015). Teaching basic fiberoptic intubation skills in a simulator: initial learning and skills decay. Journal of Anesthesia. 30(1). 12–19. 26 indexed citations
7.
Kim, Seongho, et al.. (2013). Bayesian lead time estimation for the Johns Hopkins Lung Project data. SHILAP Revista de lepidopterología. 3(3). 157–157. 9 indexed citations
8.
Wu, Dongfeng, Karen Kafadar, Gary L. Rosner, & Lyle D. Broemeling. (2012). The Lead Time Distribution When Lifetime is Subject to Competing Risks in Cancer Screening. The International Journal of Biostatistics. 8(1). 9 indexed citations
9.
Cambon, A., et al.. (2011). Evaluating the long-term effect of FOBT in colorectal cancer screening. Cancer Epidemiology. 36(1). e54–e60. 6 indexed citations
10.
Wu, Dongfeng & Adriana Pérez. (2011). A limited review of over diagnosis methods and long-term effects in breast cancer screening. Oncology Reviews. 5(3). 143–147. 10 indexed citations
11.
Chen, Yinlu, Guy Brock, & Dongfeng Wu. (2010). Estimating key parameters in periodic breast cancer screening—Application to the Canadian National Breast Screening Study data. Cancer Epidemiology. 34(4). 429–433. 14 indexed citations
12.
Wu, Dongfeng, et al.. (2010). Sojourn time and lead time projection in lung cancer screening. Lung Cancer. 72(3). 322–326. 37 indexed citations
13.
Wu, Dongfeng, et al.. (2008). When Sensitivity is a Function of Age and Time Spent in the Preclinical State in Periodic Cancer Screening. Journal of Modern Applied Statistical Methods. 7(1). 297–303. 4 indexed citations
14.
Wu, Dongfeng, et al.. (2008). Estimating key parameters in FOBT screening for colorectal cancer. Cancer Causes & Control. 20(1). 41–46. 11 indexed citations
15.
Wu, Dongfeng, Gary L. Rosner, & Lyle D. Broemeling. (2007). Bayesian Inference for the Lead Time in Periodic Cancer Screening. Biometrics. 63(3). 873–880. 20 indexed citations
16.
Wu, Dongfeng, et al.. (2005). Simulation Procedure In Periodic Cancer Screening Trials. Journal of Modern Applied Statistical Methods. 4(2). 522–527. 2 indexed citations
17.
Wu, Dongfeng, Gary L. Rosner, & Lyle D. Broemeling. (2005). MLE and Bayesian Inference of Age‐Dependent Sensitivity and Transition Probability in Periodic Screening. Biometrics. 61(4). 1056–1063. 38 indexed citations
18.
Wu, Jixiang, Johnie N. Jenkins, Jack C. McCarty, & Dongfeng Wu. (2005). Variance Component Estimation Using the Additive, Dominance, and Additive × Additive Model When Genotypes Vary across Environments. Crop Science. 46(1). 174–179. 29 indexed citations
19.
Wu, Dongfeng. (2002). Norm Thresholding Method in Wavelet Regression. Journal of Statistical Computation and Simulation. 72(3). 233–245. 2 indexed citations
20.
Shen, Yu, Dongfeng Wu, & Marvin Zelen. (2001). Testing the Independence of Two Diagnostic Tests. Biometrics. 57(4). 1009–1017. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026